Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Cannasouth for InfoPages here.
Cannasouth - Latest News [Page 1]
Cannasouth: First NZ Company To Receive Product Verification For Fully Local Dried Medicinal Cannabis Flower
Tuesday, 31 October 2023, 10:32 am | Cannasouth
In a landmark achievement for Aotearoa New Zealand, Cannasouth has obtained product verification for its EU GMP quality dried medicinal cannabis flower product. The New Zealand Medicinal Cannabis Agency (the Agency) verification marks a significant ... More >>
Cannasouth: First NZ Medicinal Cannabis Company to Begin Delivering Active Pharmaceutical Ingredients to Australia
Friday, 15 September 2023, 6:20 am | Cannasouth
In an industry first for Aotearoa New Zealand, Cannasouth Limited (NZX:CBD) has exported its inaugural commercial shipment of cannabis-based active pharmaceutical ingredients (API) to Australia. Cannasouth CEO Mark Lucas stated that this initial ... More >>
Cannasouth Receives GMP Licence To Manufacture Medicines
Friday, 19 May 2023, 12:32 pm | Cannasouth
Cannasouth Limited (NZX:CBD) is pleased to announce it has received its Licence to Manufacture Medicines to produce dried cannabis flower (to the globally recognised GMP standard) at its cultivation facility. To obtain this licence, Cannasouth had ... More >>
Leading Medicinal Cannabis Companies Cannasouth And Eqalis Announce Prospective Merger
Tuesday, 20 December 2022, 9:56 am | Cannasouth
Two leading medicinal cannabis companies have today announced a binding agreement to advance a potential 50:50 merger to truly improve patient access to cannabis-based medicines. Cannasouth and Eqalis will come together to deliver better outcomes for ... More >>
Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain
Tuesday, 9 August 2022, 11:10 am | Cannasouth
Cannasouth research shows cannabinoids could provide relief for thousands of New Zealanders from debilitating neuropathic pain A three-year neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could ... More >>
Cannasouth Signs Three-year Supplier Agreement With German-based WEECO Pharma
Thursday, 14 July 2022, 4:14 pm | Cannasouth
Cannasouth has today signed a supplier agreement with WEECO Pharma GMBH based in Germany for the supply of cannabis flower from New Zealand into Europe. The total value of the agreement could be worth between NZ$12 million and NZ$15 million over ... More >>
First Medicinal Cannabis Products Will Deliver Wider Treatment Options To Patients
Thursday, 19 May 2022, 1:05 pm | Cannasouth
Successful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand patients and prescribers. Cannasouth has had three products successfully assessed by the Government’s ... More >>
Cannasouth Opens $6 Million Capital Raising To Fund Revenue-generating Growth Phase
Friday, 16 July 2021, 9:51 am | Cannasouth
Medicinal cannabis company, Cannasouth Limited (NZX:CBD), announced this morning that it has opened a $6 million offer to consolidate its operations to take full advantage of the revenue opportunities ahead of it. Earlier this month, Cannasouth ... More >>
Cannasouth To Buy Out Cultivation And Manufacturing Joint Venture Partners
Monday, 5 July 2021, 9:58 am | Cannasouth
Leading medicinal cannabis company, Cannasouth Limited has today entered into two conditional agreements to acquire the balance of the stakes that it does not already own in its cultivation and manufacturing joint venture businesses. Acquisition of ... More >>
Cannasouth Commissions Growing Facility As It Gears Up For International Exports
Monday, 28 June 2021, 12:38 pm | Cannasouth
NZX listed medicinal cannabis company Cannasouth expects to be ready to export pharmaceutical grade cannabis flower in early 2022 after completing commissioning of its Waikato-based growing facility. Cannasouth’s joint venture partner, Cannasouth Cultivation Limited, ... More >>
Cannasouth Joins Forces With Leading US Cultivation Company
Tuesday, 21 July 2020, 6:51 pm | Cannasouth
Through its joint venture subsidiary, Cannasouth Cultivation Limited (CCL), Cannasouth Limited has entered into a service agreement with EAH Enterprises LLC, trading as Vera Cultivation in Colorado, USA. Vera Cultivation (Vera) is a US market leader ... More >>
Experienced Healthcare Marketer Joins Cannasouth To Lead First Products To Market
Tuesday, 21 July 2020, 6:49 pm | Cannasouth
NZX listed medicinal cannabis company, Cannasouth Limited has appointed experienced healthcare sales and marketing executive John Sanders as Chief Commercial Officer. Sanders will be responsible for developing and implementing marketing and sales strategies ... More >>
Cannasouth Raises More Than $6m In New Capital
Monday, 4 May 2020, 10:53 am | Cannasouth
Cannasouth’s recently closed Share Purchase Plan (SPP) has raised a total of $5,690,014 through the issue of 14,973,721 new ordinary fully paid shares. The SPP has not been scaled. Cannasouth received excess acceptances of $690,014 under the SPP, and the ... More >>
Cannasouth Announces Share Purchase Plan
Wednesday, 15 April 2020, 9:04 am | Cannasouth
Cannasouth has today announced an offer of existing ordinary shares to raise NZ$3 million pursuant to a Share Purchase Plan (SPP) to existing shareholders to accelerate development of the Company’s key initiatives following the commencement of the ... More >>
Cannasouth appoints experienced new CFO
Thursday, 23 January 2020, 12:52 pm | Cannasouth
New Zealand’s only NZX listed medicinal cannabis company Cannasouth has appointed Colin Foster as the company’s new Chief Financial Officer. More >>
Cannasouth secures consent for new cultivation facility
Monday, 23 December 2019, 1:11 pm | Cannasouth
Cannasouth’s joint venture partner Cannasouth Cultivation Limited has received resource consent for construction of its world-class medicinal cannabis cultivation facility in the Waikato. More >>
Cannasouth expands with 60% stake in Midwest Pharmaceutics
Tuesday, 1 October 2019, 11:13 am | Cannasouth
Leading medicinal cannabis company, Cannasouth Limited (NZX: CBD) (“Cannasouth” or “the Company”) is pleased to announce it has today entered into an agreement to acquire a 60 per cent shareholding in Hawkes Bay-based Midwest Pharmaceutics NZ ... More >>
Cannasouth welcomes new shareholders
Friday, 6 September 2019, 10:44 am | Cannasouth
Cannasouth has welcomed more than 550 new shareholders onto its share register since listing on the Main Board of the New Zealand Stock Exchange on June 19 this year. More >>
Cannasouth harvests 1st crop of medicinal research cannabis
Friday, 16 August 2019, 8:12 am | Cannasouth
Cannasouth has harvested its first crop of medicinal research cannabis from its purpose-built growing facility in Hamilton. More >>
Cannasouth announces cannabis cultivation venture
Wednesday, 14 August 2019, 1:00 pm | Cannasouth
Cannasouth today announced a long-term strategic joint venture (JV) with Aaron Craig and his family (Craig Family Interests) to construct and develop a world-class cannabis cultivation facility in the Waikato. More >>
